Pharma Industry News

IRVINE, Calif., Nov. 20 /PRNewswire-FirstCall/ -- Masimo Corporation (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, today announced that its management is scheduled to present at the 21st Annual Piper Jaffray Health Care Conference at the New York Palace Hotel in New York on Tuesday, December 1, 2009, at 12:00 p.m. ET.

IRVING, Texas, Nov. 20 /PRNewswire/ -- RBC Life Sciences, Inc. (OTC Bulletin Board: RBCL), a provider of proprietary nutritional supplements, wound care and pain management products, reported today company-wide net sales of $6.49 million for the quarter ended September 30, 2009, compared to net sales of $9.93 million for the same quarter last year.

The Hill reports that former Senate Majority Leader Tom Daschle helped Obama Administration officials strategize to win health care reform votes from Senators on Capitol Hill Wednesday.

WASHINGTON, Nov. 20 /PRNewswire-USNewswire/ -- An emerging body of evidence suggests that the changing global climate is already affecting infectious disease transmission patterns. As noted today in a symposium at the 58th annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH), such changes are expected to have a profound impact on global public health.

Reuters: "Congressional Democrats are seeking government investigations into recent price increases of brand-name prescription drugs, as Congress finalizes an overhaul of the healthcare system.

ARLINGTON, Va., Nov. 20 /PRNewswire-USNewswire/ -- The upcoming holiday season is full of reasons for good cheer, but the added demands of the season can also stress the capacities of our bodies.

'Blot' On U.S. HIV/AIDS Leadership Removed A "blot" on U.S. HIV/AIDS leadership "ended last month when President [Barack] Obama lifted the prohibition" that kept HIV-positive foreigners from visiting the U.S. or seeking residency, according to a

ROCKVILLE, Md., Nov. 20 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it intends to offer shares of its common stock in an underwritten public offering. Piper Jaffray & Co. and Lazard Capital Markets LLC are acting as joint book running managers.

Trading Review for Vivus Inc. Issued by Beacon Equity

Trading Markets - 13 minutes ago
DALLAS, Nov 20, 2009 (GlobeNewswire via COMTEX) -- VVUS -- BeaconEquity.com announces an investment report featuring biopharmaceutical company Vivus Inc. (Nasdaq:VVUS). The report includes ...

Pfizer and the Drugs for Neglected Diseases Initiative (DNDi) on Wednesday announced plans to team up in an effort to identify new drug candidates for the treatment of three tropical diseases, the Associated Press/Business Week reports. The scientists will test the efficacy of Pfizer drug candidates against sleeping sickness, visceral leishmaniasis, and Chagas disease.